Nektar Therapeutics
NKTR
#4555
Rank
โ‚น243.14 B
Marketcap
โ‚น7,197
Share price
0.85%
Change (1 day)
265.63%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -โ‚น13.64 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚น55.63 Million. In 2025 the company made an earning of -โ‚น14.83 Billion a decrease over its 2024 earnings that were of -โ‚น11.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น13.64 Billion-8.03%
2025 -โ‚น14.83 Billion30.44%
2024 -โ‚น11.37 Billion-56.85%
2023 -โ‚น26.34 Billion-24.31%
2022 -โ‚น34.8 Billion-30.25%
2021 -โ‚น49.88 Billion17.87%
2020 -โ‚น42.32 Billion0.88%
2019 -โ‚น41.95 Billion-164.46%
2018 โ‚น65.07 B-810.61%
2017 -โ‚น9.16 Billion-37.06%
2016 -โ‚น14.56 Billion89.22%
2015 -โ‚น7.69 Billion48.22%
2014 -โ‚น5.19 Billion-65.93%
2013 -โ‚น15.23 Billion-6.81%
2012 -โ‚น16.35 Billion28.95%
2011 -โ‚น12.68 Billion258.8%
2010 -โ‚น3.54 Billion-63.94%
2009 -โ‚น9.8 Billion-392.45%
2008 โ‚น3.34 B-211.74%
2007 -โ‚น3 Billion-79.57%
2006 -โ‚น14.68 Billion-16.9%
2005 -โ‚น17.66 Billion81.53%
2004 -โ‚น9.73 Billion54.19%
2003 -โ‚น6.31 Billion-33.87%
2002 -โ‚น9.54 Billion-9.6%
2001 -โ‚น10.56 Billion73.39%
2000 -โ‚น6.09 Billion108.9%
1999 -โ‚น2.92 Billion39.48%
1998 -โ‚น2.09 Billion60.02%
1997 -โ‚น1.31 Billion18.05%
1996 -โ‚น1.11 Billion31.82%
1995 -โ‚น0.84 Billion57.14%
1994 -โ‚น0.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.476 T-17,168.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.009 T-7,058.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น866.17 B-6,070.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น48.43 Billion 233.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.253 T-8,740.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.397 T-9,734.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น0.50 B-103.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น22.61 B-255.84%๐Ÿ‡ฎ๐Ÿ‡ช Ireland